Contract facts
UnrestrictedNo full NAICS 622110 intel page yet. Browse NAICS intelligence
MEDICAL SUPPLIES AND REAGENTS SUCH AS COBAS OMNI PROCESSING PLATE, KIT COBAS 6800/8800 SPEC DIL REAGENT IVD, KIT COBAS PCR URINE 100 PKT IVD is a federal Unrestricted award for Defense Health Agency held by Roche Diagnostics Corp. Estimated value $540K ($540K obligated). Current period of performance ends Oct 22, 2022. Last award drew 1 bidder. Place of performance: BETHESDA MD.
MEDICAL SUPPLIES AND REAGENTS SUCH AS COBAS OMNI PROCESSING PLATE, KIT COBAS 6800/8800 SPEC DIL REAGENT IVD, KIT COBAS PCR URINE 100 PKT IVD
Recompete timing
PublicCurrent PoP ended Oct 22, 2022 (1439 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on HT001422F0059? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT001422F0059?
HT001422F0059 (Medical supplies and reagents SUCH as) is a Defense Health Agency award with a potential value of $540K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT0014-22-F-0059?
HT0014-22-F-0059 is the dashed form of PIID HT001422F0059 (Medical supplies and reagents SUCH as), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT001422F0059?
Defense Health Agency awarded HT001422F0059 to Roche Diagnostics Corp (potential $540K).
Who is the incumbent on HT001422F0059?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Oct 22, 2022.
When does Roche Diagnostics Corp’s HT001422F0059 come up for recompete?
SCOUT tracks a period-of-performance end of Oct 22, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT001422F0059? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.